Yuanxiang Lin
机构:Fujian Medical University, First Affiliated Hospital of Fujian Medical University · ORCID:0000-0001-5803-2644
发表论文 244 篇 · 总被引 2838 次 · h-index 27
代表论文
- Targeting ferroptosis and mitophagy with neutrophil-inspired nanozyme for Parkinson's disease therapy (2025 · Journal of Controlled Release · 被引 22)
- A glutathione-responsive ferroptotic inducer with elevated labile iron pool and self-supplied peroxide for chemodynamic therapy (2025 · Materials Today Bio · 被引 14)
- Single-atom nanozyme-mediated dihydroartemisinin delivery for self-enhanced chemodynamic therapy and ferroptosis (2025 · Materials Today Bio · 被引 11)
- Pathogenesis Activated “In Situ Disassembly‐Reassembly” Pattern Dual‐Scavenges Cell‐Free DNA/ROS for Hemorrhagic Stroke Management (2025 · Advanced Functional Materials · 被引 9)
- In Situ Proliferating Peptide Nanoparticle Augments Multi‐Target Intervention of Secondary Brain Damage Following Subarachnoid Hemorrhage (2025 · Advanced Science · 被引 7)
- Biomaterial-based vascularization strategies for enhanced treatment of peripheral arterial disease (2025 · Journal of Nanobiotechnology · 被引 5)